APA (7th ed.) Citation

MJ, Z., M, P., X, Y., JD, L., X, C., KLR, B., . . . A, G. (2021). Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications. Clinical pharmacology and therapeutics, 109(1), 55. https://doi.org/10.1002/cpt.1916

Chicago Style (17th ed.) Citation

MJ, Zamek-Gliszczynski, et al. "Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications." Clinical Pharmacology and Therapeutics 109, no. 1 (2021): 55. https://doi.org/10.1002/cpt.1916.

MLA (9th ed.) Citation

MJ, Zamek-Gliszczynski, et al. "Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications." Clinical Pharmacology and Therapeutics, vol. 109, no. 1, 2021, p. 55, https://doi.org/10.1002/cpt.1916.